There were 153 press releases posted in the last 24 hours and 440,188 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image